BIOMAT Database Logo BIOMAT Database Logo

[The capacity of Yersinia pestis toxin to decrease the functional response of human thrombocytes to stimulation by hormones]. 1993

T D Cherkasova, and V N Bochkov, and V A Iurkiv, and V I Pokrovskiĭ

Yersinia pestis toxin (fraction II by E. Baker) (YPT) inhibited the aggregation of human platelets as well as elevation of [Ca2+], induced by different agonists (ADP, PAF, Thrombin). Agonist-induced Ca2+ mobilization and Ca2+ influx were dose-dependently inhibited by the toxin. The effect was rapid, developing during the first minute of incubation with toxin. In contrast to murine lethal protein (MLP), the platelet-inhibiting activity was thermostable and was eliminated in the course of MLA purification from YPT. These data indicate that Yersinia pestis component, unlike MLP, could influence the Ca(2+)-dependent processes in human platelets.

UI MeSH Term Description Entries
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D010975 Platelet Aggregation Inhibitors Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. Antiaggregants, Platelet,Antiplatelet Agent,Antiplatelet Agents,Antiplatelet Drug,Blood Platelet Aggregation Inhibitor,Blood Platelet Antagonist,Blood Platelet Antiaggregant,PAR-1 Antagonists,Platelet Aggregation Inhibitor,Platelet Antagonist,Platelet Antagonists,Platelet Antiaggregant,Platelet Antiaggregants,Platelet Inhibitor,Protease-Activated Receptor-1 Antagonists,Antiplatelet Drugs,Blood Platelet Aggregation Inhibitors,Blood Platelet Antagonists,Blood Platelet Antiaggregants,Platelet Inhibitors,Agent, Antiplatelet,Aggregation Inhibitor, Platelet,Antagonist, Blood Platelet,Antagonist, Platelet,Antiaggregant, Blood Platelet,Antiaggregant, Platelet,Drug, Antiplatelet,Inhibitor, Platelet,Inhibitor, Platelet Aggregation,PAR 1 Antagonists,Platelet Antagonist, Blood,Platelet Antiaggregant, Blood,Protease Activated Receptor 1 Antagonists
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D003864 Depression, Chemical The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Depression,Chemical Depressions,Depressions, Chemical
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000244 Adenosine Diphosphate Adenosine 5'-(trihydrogen diphosphate). An adenine nucleotide containing two phosphate groups esterified to the sugar moiety at the 5'-position. ADP,Adenosine Pyrophosphate,Magnesium ADP,MgADP,Adenosine 5'-Pyrophosphate,5'-Pyrophosphate, Adenosine,ADP, Magnesium,Adenosine 5' Pyrophosphate,Diphosphate, Adenosine,Pyrophosphate, Adenosine
D001427 Bacterial Toxins Toxic substances formed in or elaborated by bacteria; they are usually proteins with high molecular weight and antigenicity; some are used as antibiotics and some to skin test for the presence of or susceptibility to certain diseases. Bacterial Toxin,Toxins, Bacterial,Toxin, Bacterial
D013268 Stimulation, Chemical The increase in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Stimulation,Chemical Stimulations,Stimulations, Chemical

Related Publications

T D Cherkasova, and V N Bochkov, and V A Iurkiv, and V I Pokrovskiĭ
[Ability of a lipopolysaccharide toxin to intensify the functional response of human thrombocytes to thrombin stimulation].
February 1988, Biulleten' eksperimental'noi biologii i meditsiny,
T D Cherkasova, and V N Bochkov, and V A Iurkiv, and V I Pokrovskiĭ
[The fibronectin-binding capacity of Yersinia pestis].
January 1993, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
T D Cherkasova, and V N Bochkov, and V A Iurkiv, and V I Pokrovskiĭ
The serological response to Yersinia pestis infection.
January 1977, Bulletin of the World Health Organization,
T D Cherkasova, and V N Bochkov, and V A Iurkiv, and V I Pokrovskiĭ
Preparation of Yersinia pestis plague murine toxin.
January 1988, Methods in enzymology,
T D Cherkasova, and V N Bochkov, and V A Iurkiv, and V I Pokrovskiĭ
[Yersinia pestis "muscle" toxin: some enzyme activities].
December 1995, Biulleten' eksperimental'noi biologii i meditsiny,
T D Cherkasova, and V N Bochkov, and V A Iurkiv, and V I Pokrovskiĭ
[The cytokine-inducing activity of the Yersinia pestis "murine" toxin].
January 1998, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
T D Cherkasova, and V N Bochkov, and V A Iurkiv, and V I Pokrovskiĭ
[Functional state of thrombocytes in Yersinia infection].
January 1991, Vestnik Akademii meditsinskikh nauk SSSR,
T D Cherkasova, and V N Bochkov, and V A Iurkiv, and V I Pokrovskiĭ
Caspase-12 and the inflammatory response to Yersinia pestis.
September 2009, PloS one,
T D Cherkasova, and V N Bochkov, and V A Iurkiv, and V I Pokrovskiĭ
Beta-adrenergic blocking activity of Yersinia pestis murine toxin.
October 1977, Infection and immunity,
T D Cherkasova, and V N Bochkov, and V A Iurkiv, and V I Pokrovskiĭ
Functional and structural analysis of HicA3-HicB3, a novel toxin-antitoxin system of Yersinia pestis.
November 2014, Journal of bacteriology,
Copied contents to your clipboard!